Investigation into the efficacy of IL-1b AcTaleukins as adjuvant for cancer immunotherapy. Ghent University
The Interleukin-1 (IL-1) family consists of a group of cytokines with potent immuno-stimulatory
activities. Several studies indicate that activation of leukocyte subsets by IL-1 is essential for
protective immunity against a variety of pathogens and for elimination of cancer cells. IL-1 could
have therapeutic value, for instance as vaccine adjuvant, yet its clinical application is hampered by
the ...